Abbott Laboratories · NSN 6505-01-386-2721 · FSC 6505 · No Item Name Available
Verified by PartsTable
NSN 6505-01-386-2721 — this item is cataloged by the U.S. Government under National Stock Number 6505-01-386-2721. Primary manufacturer part number: NDC 00074-7120-07-07.
6505-01-386-2721 — No Item Name Available illustration
Features
Dextrose Injection — FSC 6505
Medical Designation and Grade: UNITED STATES PHARMACOPEIA
Active Medicament Medicinal Strength: 70.000 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT
2 verified cross-references
Primary manufacturer: Abbott Laboratories
Applications
Industrial maintenance and repair
Government and military logistics
Equipment overhaul and refurbishment
General Description
The Dextrose Injection, cataloged under National Stock Number 6505-01-386-2721, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Abbott Laboratories. Government technical data includes 5 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 2 commercial cross-references from 1 manufacturer, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active.
NSN 6505-01-386-2721 is a Dextrose Injection, manufactured by Abbott Laboratories, classified under FSC 6505 (No Item Name Available). Status: active.
What are the part numbers for NSN 6505-01-386-2721?
NSN 6505-01-386-2721 has 2 cross-referenced part numbers: NDC 00074-7120-07-07 (Abbott Laboratories), 7120 (Abbott Laboratories).
What NSN replaces 6505-01-386-2721?
There are 12 known substitutes for 6505-01-386-2721: 4510-00-105-1435, 2815-00-146-2298, 5905-00-155-6993 and 9 more. Verify interchangeability with system specifications before substitution.
What are the specifications of NDC 00074-7120-07-07?
Key specifications for NDC 00074-7120-07-07: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Content Quantity: 2000.000 MILLILITERS; Primary Container Type: BAG, PLASTIC; Administration: INTRAVENOUS. 5 total characteristics are documented in the Federal Logistics Information System.
✓ Validated with multiple authoritative sources, including Government, OEM, and Certified sources.